1-benzylimidazole has been researched along with ozagrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bureik, M; Du, W; Li, H; Liu, S; Machalz, D; Sharma, S; Wolber, G | 1 |
| Fornabaio, D; Mullane, KM | 1 |
2 other study(ies) available for 1-benzylimidazole and ozagrel
| Article | Year |
|---|---|
Discovery of a novel potent cytochrome P450 CYP4Z1 inhibitor.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P450 Family 4; Drug Discovery; Humans; Imidazoles; MCF-7 Cells; Methacrylates; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rabbits; Structure-Activity Relationship | 2021 |
Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.
Topics: Acrylates; Animals; Aspirin; Biomechanical Phenomena; Blood Platelets; Coronary Disease; Cyclooxygenase Inhibitors; Dogs; Imidazoles; Methacrylates; Myocardial Infarction; Thromboxane-A Synthase | 1988 |